SOURCE: S3 Investment Company

July 11, 2006 10:10 ET

S3 Investment Company Attends Medical Trade Event With Subsidiary SINO UJE and New Supplier, For Life

TEMECULA, CA -- (MARKET WIRE) -- July 11, 2006 -- S3 Investment Company, Inc. (OTCBB: SEIH) today announced that chief executive officer Jim Bickel, along with Li Jun, the managing director of S3 subsidiary SINO UJE, Ltd., attended a major medical trade event with representatives of new supplier For Life GmbH in Hong Kong last week. Mr. Bickel and Mr. Li attended the 16th Biennial Congress of the World Council of Enterostomal Therapists (www.wcet2006.com.hk/public/main_page/index.asp), which was held from July 2-6 at the Hong Kong Convention and Exhibition Centre, and is one of the largest programs of its kind in the world.

The purpose of SINO UJE's attendance at the event was to prepare for a comprehensive marketing program on behalf of For Life's Stomocur brand colostomy products throughout China.

"We are working with SINO UJE and For Life to ensure the most successful distribution for the Stomocur colostomy products in China," stated Mr. Bickel. "Our experience at this event validated the belief that there is significant interest in the Stomocur product line, and we expect to see immediate sales to a variety of end-users, including hospitals, clinics and other healthcare facilities."

Stomocur's two-piece system has received State Food and Drug Administration (SFDA) approval and is now permitted to be sold on the Chinese market.

"The greater the awareness of this product line, the sooner we will have widespread distribution throughout China. SINO UJE's sales team, headed by Mr. Li, is well-prepared to foster the growth of the Stomocur line in China, and we were pleased to take part in this important medical trade show," added Mr. Bickel.

S3 is also preparing for its annual meeting, which will be held later this week on July 13, 2006, at 1:00 p.m. Pacific time at the company's corporate offices. The proxy requests shareholder votes on several proposals under consideration, as well as any other business that may properly come before the meeting. Shareholders are asked to return their completed proxies by mail in the return envelope provided or send by facsimile to Transfer Online at 503-227-6874. Votes can also be taken by telephone at 1-800-454-8683 or online at www.proxyvote.com.

To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.s3investments.com/ealert.asp.

About S3 Investment Company

S3 Investment Company, Inc. (www.s3investments.com) is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    (951) 587-8072
    Email Contact

    Equiti-trend Advisors LLC
    Investor Communication Representatives
    Toll-Free (800) 585-6988